TETRALOGIC PHARMACEUTICALS CORP Debt Conversion, Original Debt, Amount
TETRALOGIC PHARMACEUTICALS CORP reported Debt Conversion, Original Debt, Amount of $2.08 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, original debt, amount for the quarter ending 2015-12-31 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, original debt, amount for the quarter ending 2015-09-30 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, original debt, amount for the quarter ending 2015-06-30 was $0.00.
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, original debt, amount for the quarter ending 2015-03-31 was $2.08M.
- TETRALOGIC PHARMACEUTICALS CORP debt conversion, original debt, amount for fiscal 2015 was $2.08M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 derived: sum of 3 quarters · filed 2016-11-03 | $2.08M 10-K · filed 2016-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $2.08M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $2.08M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $2.08M 10-Q · filed 2016-05-04 |